These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23867826)

  • 21. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
    Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
    Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression profile of microrna-145 in urothelial bladder cancer.
    Dip N; Reis ST; Srougi M; Dall'Oglio MF; Leite KR
    Int Braz J Urol; 2013; 39(1):95-101; discussion 102. PubMed ID: 23489501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas.
    Wang Y; Luo H; Li Y; Chen T; Wu S; Yang L
    Mol Med Rep; 2012 Jan; 5(1):260-5. PubMed ID: 21993544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
    Zhang Q; Wang LQ; Wong KY; Li ZY; Chim CS
    J Clin Pathol; 2015 Jul; 68(7):557-61. PubMed ID: 25855800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic regulation of miR-196b expression in gastric cancer.
    Tsai KW; Hu LY; Wu CW; Li SC; Lai CH; Kao HW; Fang WL; Lin WC
    Genes Chromosomes Cancer; 2010 Nov; 49(11):969-80. PubMed ID: 20662076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA expression signatures of bladder cancer revealed by deep sequencing.
    Han Y; Chen J; Zhao X; Liang C; Wang Y; Sun L; Jiang Z; Zhang Z; Yang R; Chen J; Li Z; Tang A; Li X; Ye J; Guan Z; Gui Y; Cai Z
    PLoS One; 2011 Mar; 6(3):e18286. PubMed ID: 21464941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].
    Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA
    Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer.
    Wee EJ; Peters K; Nair SS; Hulf T; Stein S; Wagner S; Bailey P; Lee SY; Qu WJ; Brewster B; French JD; Dobrovic A; Francis GD; Clark SJ; Brown MA
    Oncogene; 2012 Sep; 31(38):4182-95. PubMed ID: 22231446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer.
    Wiklund ED; Bramsen JB; Hulf T; Dyrskjøt L; Ramanathan R; Hansen TB; Villadsen SB; Gao S; Ostenfeld MS; Borre M; Peter ME; Ørntoft TF; Kjems J; Clark SJ
    Int J Cancer; 2011 Mar; 128(6):1327-34. PubMed ID: 20473948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
    Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
    J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism.
    Ji W; Yang L; Yuan J; Yang L; Zhang M; Qi D; Duan X; Xuan A; Zhang W; Lu J; Zhuang Z; Zeng G
    Carcinogenesis; 2013 Feb; 34(2):446-53. PubMed ID: 23125218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epigenetic inactivation of microRNA genes in mammary carcinoma].
    Lehmann U; Hasemeier B; Römermann D; Müller M; Länger F; Kreipe H
    Verh Dtsch Ges Pathol; 2007; 91():214-20. PubMed ID: 18314617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family.
    Wong KY; Yu L; Chim CS
    Epigenomics; 2011 Feb; 3(1):83-92. PubMed ID: 22126155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.
    Veerla S; Lindgren D; Kvist A; Frigyesi A; Staaf J; Persson H; Liedberg F; Chebil G; Gudjonsson S; Borg A; Månsson W; Rovira C; Höglund M
    Int J Cancer; 2009 May; 124(9):2236-42. PubMed ID: 19127597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.
    Tsuruta T; Kozaki K; Uesugi A; Furuta M; Hirasawa A; Imoto I; Susumu N; Aoki D; Inazawa J
    Cancer Res; 2011 Oct; 71(20):6450-62. PubMed ID: 21868754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer.
    Dokun OY; Florl AR; Seifert HH; Wolff I; Schulz WA
    Int J Cancer; 2008 Dec; 123(12):2798-807. PubMed ID: 18803290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression.
    Bo J; Yang G; Huo K; Jiang H; Zhang L; Liu D; Huang Y
    FEBS J; 2011 Mar; 278(5):786-92. PubMed ID: 21205209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.